Search research articles
Contact Us
Filters
Showing results (151-160 of 171) with videos related to
Page
of 18
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 2, 2025
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY
Greco B Malijan, Rebecca J Sardell, Natalie Staplin, et al.
F1000Research
|
February 3, 2021
Maternal and perinatal Health Research Collaboration, India (MaatHRI): methodology for establishing a hospital-based research platform in a low and middle income country setting
Manisha Nair, Babul Bezbaruah, Amrit Krishna Bora, et al.
Transplantation Research
|
May 7, 2013
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol
Richard Haynes, Colin Baigent, Paul Harden, et al.
Lancet (London, England)
|
August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology
|
June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis
William N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
November 25, 2017
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials
Werner Hacke, Patrick Lyden, Jonathan Emberson, et al.
Lancet (London, England)
|
September 1, 2022
Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials
Alex Pitcher, Enti Spata, Jonathan Emberson, et al.
Journal of the American Society of Nephrology : JASN
|
December 12, 2023
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD
Kaitlin J Mayne, Natalie Staplin, David F Keane, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 13, 2025
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy
Doreen Zhu, Parminder K Judge, Susan T Francis, et al.
European Heart Journal
|
January 15, 2004
Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology
Carlo Patrono, Fedor Bachmann, Colin Baigent, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 171) with videos related to
Sort By:
Page
of 18
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 2, 2025
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY
Greco B Malijan, Rebecca J Sardell, Natalie Staplin, et al.
F1000Research
|
February 3, 2021
Maternal and perinatal Health Research Collaboration, India (MaatHRI): methodology for establishing a hospital-based research platform in a low and middle income country setting
Manisha Nair, Babul Bezbaruah, Amrit Krishna Bora, et al.
Transplantation Research
|
May 7, 2013
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol
Richard Haynes, Colin Baigent, Paul Harden, et al.
Lancet (London, England)
|
August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology
|
June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis
William N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
November 25, 2017
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials
Werner Hacke, Patrick Lyden, Jonathan Emberson, et al.
Lancet (London, England)
|
September 1, 2022
Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials
Alex Pitcher, Enti Spata, Jonathan Emberson, et al.
Journal of the American Society of Nephrology : JASN
|
December 12, 2023
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD
Kaitlin J Mayne, Natalie Staplin, David F Keane, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 13, 2025
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy
Doreen Zhu, Parminder K Judge, Susan T Francis, et al.
European Heart Journal
|
January 15, 2004
Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology
Carlo Patrono, Fedor Bachmann, Colin Baigent, et al.
Page
of 18